Literature DB >> 29055286

In Defense of Progesterone: A Review of the Literature.

Allan Lieberman, Luke Curtis.   

Abstract

Context • The medical literature on the use of progesterone in postmenopausal women is often confusing and contradictory. Some physicians implicate natural progesterone in an increase in the risk of breast cancer. The chemical structure of natural progesterone (P4) is quite different from chemically altered, synthetic chemicals called progestins, which results in different actions at the cell level. Objective • The research team intended to review the literature to examine the benefits and safety of natural progesterone and determine whether it can cause an increase or decrease in breast cancer risk. Design • A review of the medical literature to examine the benefits and safety of natural progesterone as compared with synthetic progestins. Intervention • Studies examined compared controls not receiving hormone therapy with women receiving estrogen alone and in combination with natural progesterone and with various synthetic progestins, such as medroxyprogesterone acetate-the most commonly used synthetic progestin. Outcome Measures • Outcome measures included factors such as progression and survival of breast and other cancers and other epidemiological and laboratory data. Results • A meta-analysis of 3 studies involving 86 881 postmenopausal women reported that the use of natural progesterone was associated with a significantly lower risk of breast cancer compared with synthetic progestins. Anovulation and low levels of serum progesterone have been associated with a significantly higher risk of breast cancer in premenopausal women. Use of progesterone has been linked to lower rates of uterine and colon cancers and may also be useful in treating other cancers such as ovarian, melanoma, mesothelioma, and prostate. Progesterone may also be helpful in preventing cardiovascular disease and preventing and treating neurodegenerative conditions such a stroke and traumatic brain injury. Conclusions • Physicians should have no hesitation prescribing natural progesterone. The evidence is clear that progesterone does not cause breast cancer. Indeed, progesterone is protective and preventative of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055286

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  4 in total

1.  Estradiol and progesterone regulate proliferation and apoptosis in colon cancer.

Authors:  Corina Verónica Sasso; Flavia Eliana Santiano; Fiorella Campo Verde Arboccó; Leila Ester Zyla; Silvana Noemí Semino; Martin Eduardo Guerrero-Gimenez; Virginia Pistone Creydt; Constanza Matilde López Fontana; Rubén Walter Carón
Journal:  Endocr Connect       Date:  2019-03-01       Impact factor: 3.335

2.  Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway.

Authors:  Yao-Lei Zhang; Xu-Dong Wen; Xin Guo; Shang-Qing Huang; Ting-Ting Wang; Pei-Ting Zhou; Wei Li; Long-Fu Zhou; Yong-He Hu
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

Review 3.  Key to Life: Physiological Role and Clinical Implications of Progesterone.

Authors:  Bernadett Nagy; Júlia Szekeres-Barthó; Gábor L Kovács; Endre Sulyok; Bálint Farkas; Ákos Várnagy; Viola Vértes; Kálmán Kovács; József Bódis
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

4.  Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors.

Authors:  Moumita Sarkar; Harsh Sharma; Parminder Singh; Ranbala Ranu; Ravi Datta Sharma; Usha Agrawal; Rahul Pal
Journal:  iScience       Date:  2022-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.